Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zyversa Therapeutics, Inc.

Clinical trials sponsored by Zyversa Therapeutics, Inc., explained in plain language.

ZyVersa Therapeutics, Inc. ZVSA OTC

Clinical-stage biopharmaceutical company developing treatments for inflammatory and renal diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1

Kidney cleanse? experimental drug aims to flush cholesterol from damaged kidneys

Disease control Terminated

This early-stage trial planned to test an experimental drug called VAR200 (2-HPβCD) in adults with type 2 diabetes and kidney disease. The drug works by removing extra cholesterol from kidney cells, which might help protect the kidneys. However, the study was withdrawn before any…

Phase: PHASE2 • Sponsor: ZyVersa Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC